The Barcelonaβeta Brain Research Center (BBRC), the research center of the Pasqual Maragall Foundation, has participated one more in the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases, an important event for advancing research on neurodegenerative diseases. Our researchers have presented their latest findings through oral presentations, posters, and on-demand talks.
This edition has hosted four oral presentations, 2 posters & on demand talks, and Dr. Natàlia Vilor-Tejedor, researcher and leader of the Genetic Neuroepidemiology and Biostatistics team, has participated in the AlzInsights Summit, a side event of the AD/PD 2025, with a flash talk about “Leveraging AD Workbench for New Breakthrough”.
The 19th edition of the ADPD “Advances in Science & Therapy” was held in Vienna on 1-5 April. This year the conference focused on the latest breakthroughs in treatment, translational research, early diagnosis, drug development, and clinical trials for Alzheimer's, Parkinson's, and other related neurological disorders. The event brought together leading medical and scientific professionals from around the world to share insights and advancements in these fields.
BBRC’s presence at AD/PD 2025 highlights its ongoing commitment to Alzheimer’s and neuroscience research. Several members of the BBRC team attended this year’s edition to engage in networking, exchange knowledge with international experts, and stay up to date with the latest advancements in neurodegenerative disease research. Their participation reinforces BBRC’s dedication to building collaborations and incorporating the latest research into our ongoing projects. By working alongside leading experts, BBRC continues to advance progress in prevention, early detection, understanding disease mechanisms and developing potential therapeutic strategies for Alzheimer's disease.